Stellenbosch, South Africa
Biocode Technologies
ActiveHealth
South Africa
GIZ
Biocode Technologies is a health diagnostics company focusing on developing, scaling, and clinically validating microclot detection rapid test for Long COVID and other cardiovascular diseases, through partnerships with clinical diagnostics and healthcare providers.
Investment
- Country: South Africa
- Public found: EUR 100,000
- Start of Funding: 12/2024
- Public Partner: GIZ
Impact
Good Health and Well-being
Reduced Inequalities
Apply Now
develoPPP Ventures
develoPPP Ventures is aimed at young companies with an innovative business model that are active in an emerging market and want to take the next step. Through a matching funds model, the program offers public early-stage investment support.
More Information
Do you have any questions?
For general questions regarding develoPPP or other BMZ funding programmes, please contact
Ulrich Boysen
Senior Berater
Agentur für Wirtschaft & Entwicklung
Hans-Joachim Hebgen
Senior Berater
Agentur für Wirtschaft & Entwicklung
For questions regarding already concrete projects please contact the team of your implementing partner
Anja Meinecke
Programmkoordinatorin
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH